Stereotactic Conformal Radiotherapy in Non-small Cell Lung Cancer - An Overview

Clinical Oncology

Volumn 24, Issue 8, 2012, Pages 556-568

  Munshi, A ^a   Krishnatry, R ^a   Banerjee, S ^a   Agarwal, J P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Carcinoma; Lung; Radiotherapy; Stereotactic

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; DOSIMETRY; EARLY CANCER; EMPYEMA; FAILURE FREE SURVIVAL; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOBECTOMY; LUNG EMBOLISM; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC CONFORMAL RADIOTHERAPY; SURGICAL MORTALITY; THORACOTOMY; TREATMENT CONTRAINDICATION; TUMOR LOCALIZATION; TUMOR VOLUME; VIDEO ASSISTED THORACOSCOPIC SURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE;

EID: 84866003631     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.03.009     Document Type: Article

References (86)

1. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide 2009, IARC CancerBase, IARC Press, Lyon.
2. Rami-Porta R., Ball D., Crowley J. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
3. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988, 96:440-447.
4. Shields T.W. Surgical therapy for carcinoma of the lung. Clin Chest Med 1993, 14:1-7.
5. Cerfolio R.J., Bryant A.S. Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg 2009, 88:917-922.
6. Qiao X., Tullgren O., Lax I. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41:1-11.
7. Kelsey C.R., Boyd J.A., Hubbs J.L., et al. Local/regional recurrence following surgery for early-stage lung cancer: a 10-year experience with 975 patients. J Clin Oncol 2008, 26(Suppl.):7542.
8. Whitson B.A., Andrade R.S., Boettcher A., et al. Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007, 83:1965-1970.
9. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumours in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129.
10. Lee P.C., Korst R.J., Port J.L., et al. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. J Thorac Cardiovasc Surg 2006, 132:1382-1389.
11. Shiraishi T., Shirakusa T., Hiratsuka M., et al. Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control. Ann Thorac Surg 2006, 82:1021-1026.
12. Roviaro G., Varoli F., Vergani C., et al. Long-term survival after video thoracoscopic lobectomy for stage I lung cancer. Chest 2004, 126:725-732.
13. Martin A., Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol 2010, 22:157-172.
14. Oshiro Y., Aruga T., Tsuboi K., et al. Stereotactic body radiotherapy for lung tumors at the pulmonary hilum. Strahlenther Onkol 2010, 186(5):274-279.
15. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
16. Onishi H., Kuriyama K., Komiyama T., et al. Clinical outcomes of stereotactic radiotherapy for stage I non small cell lung cancer using a novel irridiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004, 45:45-55.
17. Blomgren H., Lax I., Näslund I., Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995, 34(6):861-870.
18. Lo Y.C., Ling C.C., Larson D.A. The effect of set-up uncertainties on the radiobiological advantage of multi-fraction stereotaxic radiosurgery. Int J Radiat Oncol Biol Phys 1996, 15:1113-1119.
19. Ling C.C., Lo Y., David A. Radiobiophysical aspects of stereotaxic radiation treatment of central nervous system diseases. Semin Rad Oncol 1995, 5:192-196.
20. Fuks Z., Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005, 8:89-91.
21. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early stage non-small cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
22. Dunlap N.E., James M., Paul W., et al. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT). Thorac Cardiovasc Surg 2010, 140:583-589.
23. Guckenberger M., Wulf J., Mueller G., et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009, 74:47-54.
24. Kirkpatrick J.P., Meyer J.J., Marks L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008, 18:240-243.
25. Park C., Papiez L., Zhang S. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:847-852.
26. Videtic G.M., Stephans K., Reddy C., et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys 2010, 77:344-349.
27. Grills I.S., Mangona V.S., Welsh R., et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small cell lung cancer. J Clin Oncol 2010, 28:928-935.
28. Le Q.T., Loo B.W., Ho A., et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006, 1:802-809.
29. Stereotactic body radiation therapy 2005, Lippincott, Philadelphia, PA. B.D. Kavanaugh, R.D. Timmerman (Eds.).
30. Pennathur A., Luketich J.D., Heron D.E., et al. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2009, 137:597-604.
31. Milano M.T., Constine L.S., Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiother Oncol 2008, 3:36-42.
32. McGarry R.C., Papiez L., Williams M., Whitford T., Timmerman R.D. Stereotactic body radiation therapy of early-stage nonsmall-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005, 63:1010-1015.
33. Van der Voort van Zyp N.C., van der Holt B., van Klaveren R.J., et al. Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer 2010, 69(3):296-301.
34. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
35. Haasbeek C.J., Lagerwaard F.J., Antonisse M.E., et al. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer 2010, 116:406-414.
36. Saitoh J., Saito Y., Kazumoto T., et al. Therapeutic effect of linac-based stereotactic radiotherapy with a micro-multileaf collimator for the treatment of patients with brain metastases from lung cancer. Jpn J Clin Oncol 2010, 40:119-124.
37. Ricardi U., Filippi A.R., Guarneri A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77.
38. van der Voort van Zyp N.C., Prévost J.B., van der Holt B., et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2010, 77:31-37.
39. Gomez D.R., Hunt M.A., Jackson A., et al. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 2009, 93:414-418.
40. Brown W.T., Wu X., Fayad F., et al. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol 2009, 21:623-631.
41. Stephans K.L., Djemil T., Reddy C.A., et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. Thorac Oncol 2009, 4:976-982.
42. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
43. Soliman H., Cheung P., Yeung L., et al. Accelerated hypofractionated radiotherapy for early-stage non-small-cell lung cancer: long-term results. Int J Radiat Oncol Biol Phys 2011, 79(2):459-465.
44. van der Voort van Zyp N.C., Prevost J.-B., Hoogeman M.S., et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. Radiother Oncol 2009, 91:296-300.
45. Song S.Y., Choi W., Shin S.S., et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 2009, 66:89-93.
46. Ng A.W.Y., Tung S.Y., Wong V.Y.W. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer - report on clinical outcome and dose to critical organs. Radiother Oncol 2008, 87:24-28.
47. Lagerwaard F.J., Haasbeek C.J., Smit E.F., et al. Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
48. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. Thorac Oncol 2007, 2(Suppl. 3):94-100.
49. Sinha B., McGarry R.C. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys 2006, 66:1120-1124.
50. Nyman J., Johansson K.A., Hulten U. Stereotactic hypofractionated radiotherapyfor stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006, 51:97-103.
51. Hof H., Herfarth K.K., Munter M., et al. Stereotactic single dose radiotherapy of stage I non small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003, 56:335-341.
52. Onimaru R., Fujino M., Yamazaki K., et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:374-381.
53. Tomé W.A., Fowler J.F. On cold spots in tumor subvolumes. Med Phys 2002, 29:1590-1598.
54. McCammon R., Schefter T.E., Gaspar L.E., et al. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009, 73:112-118.
55. Chen Y., Guo W., Lu Y., Zou B. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy. Radiother Oncol 2008, 88:351-358.
56. http://www.rtog.org/ClinicalTrials/Protocol/0618.pdf.
57. [accessed 10.11.11]. http://www.goldcopd.org.
58. Henderson M., McGarry R., Yiannoutsos C., et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72:404-409.
59. Stephans K.L., Djemil T., Reddy C.A., et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 2009, 4:838-844.
60. Palma D., Lagerwaard F., Rodrigues G., et al. Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012, 82(3):1149-1156.
61. Louie A.V., Rodrigues G., Hannouf M., et al. Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis. Radiother Oncol 2011, 99(2):161-165.
62. Michael T.M., Louis S.C., Paul O. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007, 17:131-140.
63. Trovo M., Linda A., Naqa I.E., et al. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 2010, 69(1):77-85.
64. Feng-Ming K., Ritter T., Quint D.J., et al. Consideration of dose limits for organ at risk of thorasic radiotherapy: atlas for lung, proximal bronchial tree, oesophagus. Int J Radiat Oncol Biol Phys 2011, 81(5):1442-1457.
65. Swensen S.J., Silverstein M.D., Ilstrup D.M., Schleck C.D., Edell E.S. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997, 157:849-855.
66. van Loon J., Offermann C., Bosmans G., et al. (18)FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 2008, 87:49-54.
67. Louie A.V., Rodrigues G., Hannouf M. Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a Markov model-based decision analysis. Int J Radiat Ovncol Biol Phys 2011, 81(4):964-973.
68. Onishi H., Shirato H., Nagata Y. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys 2011, 81(5):1352-1358.
69. Videtic G.M., Stephans K.L. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?. Curr Oncol Rep 2010, 12:235-241.
70. Chang J.Y., Cox J.D. Improving radiation conformality in the treatment of non-small cell lung cancer. Semin Radiat Oncol 2010, 20:171-177.
71. Pijls-Johannesma M., Grutters J.P., Verhaegen F. Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist 2010, 15:93-103.
72. Widesott L., Amichetti M., Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol 2008, 86:154-164.
73. Chang J.Y., Liu H.H., Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 2005, 7:255-259.
74. Miyamoto T., Baba M., Yamamoto N., et al. Curative treatment of stage I non-small cell lung cancer with carbon ion beams using a hypofractionated regime. Int J Radiat Oncol Biol Phys 2007, 67:750-758.
75. Hata M., Tokuuye K., Kagei K., et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/ II clinical study. Int J Radiat Oncol Biol Phys 2007, 68:786-793.
76. Nihei K., Ogino T., Ishikura S., et al. High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 65:107-111.
77. Bush D.A., Slater J.D., Shin B.B., et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004, 126:1198-1203.
78. Miyamoto T., Yamamoto N., Nishimura H., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003, 66:127-140.
79. Shioyama Y., Tokuuye K., Okumura T., et al. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003, 56:7-13.
80. Zhu J.C., Yan T.D., Morris D.L. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 2008, 15:1765-1774.
81. Dupuy D.E., Zagoria R.J., Akerley W., et al. Percutaneous radiofrequency ablation of malignancies in the lung. Am J Roentgenol 2000, 174(1):57-59.
82. Kim S.R., Han H.J., Park S.J. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol 2012, 81(2):395-399.
83. Sher D.J., Wee J.O., Punglia R.S., et al. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011, 81(5):767-774.
84. Zemlyak A., Moore W.H., Bilfinger T.V., et al. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010, 211:68-72.
85. Das M., Abdelmaksoud M.H., Loo B.W. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?. Curr Treat Options Oncol 2010, 11:24-35.
86. Roy A.M., Bent C., Fotheringham T. Radiofrequency ablation of lung lesions: practical applications and tips. Curr Probl Diagn Radiol 2009, 38:44-52.